291 related articles for article (PubMed ID: 37672271)
1. Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm.
Ehrhardt H; Aubert AM; Ådén U; Draper ES; Gudmundsdottir A; Varendi H; Weber T; Zemlin M; Maier RF; Zeitlin J;
JAMA Netw Open; 2023 Sep; 6(9):e2332413. PubMed ID: 37672271
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental Outcomes Among Extremely Preterm Infants 6.5 Years After Active Perinatal Care in Sweden.
Serenius F; Ewald U; Farooqi A; Fellman V; Hafström M; Hellgren K; Maršál K; Ohlin A; Olhager E; Stjernqvist K; Strömberg B; Ådén U; Källén K;
JAMA Pediatr; 2016 Oct; 170(10):954-963. PubMed ID: 27479919
[TBL] [Abstract][Full Text] [Related]
3. Postnatal growth restriction and neurodevelopment at 5 years of age: a European extremely preterm birth cohort study.
El Rafei R; Maier RF; Jarreau PH; Norman M; Barros H; Van Reempts P; Van Heijst A; Pedersen P; Cuttini M; Johnson S; Costa R; Zemlin M; Draper ES; Zeitlin J;
Arch Dis Child Fetal Neonatal Ed; 2023 Sep; 108(5):492-498. PubMed ID: 36868809
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
[TBL] [Abstract][Full Text] [Related]
5. The differential associative relationship between early risk factors, neonatal morbidities and early neurodevelopmental outcome in preterm infants <29 weeks' gestation.
Huang HB; Hicks M; Zhang QS; Watt MJ; Lin F; Wan XQ; Cheung PY
Early Hum Dev; 2023 Nov; 186():105859. PubMed ID: 37738923
[TBL] [Abstract][Full Text] [Related]
6. Associations of Maternal Milk Feeding With Neurodevelopmental Outcomes at 7 Years of Age in Former Preterm Infants.
Belfort MB; Knight E; Chandarana S; Ikem E; Gould JF; Collins CT; Makrides M; Gibson RA; Anderson PJ; Simmer K; Tiemeier H; Rumbold A
JAMA Netw Open; 2022 Jul; 5(7):e2221608. PubMed ID: 35816314
[TBL] [Abstract][Full Text] [Related]
7. Association of Pediatric Buccal Epigenetic Age Acceleration With Adverse Neonatal Brain Growth and Neurodevelopmental Outcomes Among Children Born Very Preterm With a Neonatal Infection.
Gomaa N; Konwar C; Gladish N; Au-Young SH; Guo T; Sheng M; Merrill SM; Kelly E; Chau V; Branson HM; Ly LG; Duerden EG; Grunau RE; Kobor MS; Miller SP
JAMA Netw Open; 2022 Nov; 5(11):e2239796. PubMed ID: 36322087
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g.
Brumbaugh JE; Hansen NI; Bell EF; Sridhar A; Carlo WA; Hintz SR; Vohr BR; Colaizy TT; Duncan AF; Wyckoff MH; Baack ML; Rysavy MA; DeMauro SB; Stoll BJ; Das A; Higgins RD;
JAMA Pediatr; 2019 May; 173(5):434-445. PubMed ID: 30907941
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and follow-up programmes in extreme preterm children in Denmark in the EPICE/SHIPS cohort.
Pedersen P; Bilsteen JF
Dan Med J; 2020 Mar; 67(3):. PubMed ID: 32138829
[TBL] [Abstract][Full Text] [Related]
10. Association Between Early Amino Acid Intake and Full-Scale IQ at Age 5 Years Among Infants Born at Less Than 30 Weeks' Gestation.
Rozé JC; Morel B; Lapillonne A; Marret S; Guellec I; Darmaun D; Bednarek N; Moyon T; Marchand-Martin L; Benhammou V; Pierrat V; Flamant C; Gascoin G; Mitanchez D; Cambonie G; Storme L; Tosello B; Biran V; Claris O; Picaud JC; Favrais G; Beuchée A; Loron G; Gire C; Durrmeyer X; Gressens P; Saliba E; Ancel PY;
JAMA Netw Open; 2021 Nov; 4(11):e2135452. PubMed ID: 34846527
[TBL] [Abstract][Full Text] [Related]
11. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
[No Abstract] [Full Text] [Related]
13. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
[TBL] [Abstract][Full Text] [Related]
14. Platelet Transfusion and Death or Neurodevelopmental Impairment in Children Born Extremely Preterm.
Davenport PE; Wood TR; Heagerty PJ; Sola-Visner MC; Juul SE; Patel RM
JAMA Netw Open; 2024 Jan; 7(1):e2352394. PubMed ID: 38261320
[TBL] [Abstract][Full Text] [Related]
15. Motor trajectories from birth to 5 years of children born at less than 30 weeks' gestation: early predictors and functional implications. Protocol for a prospective cohort study.
Spittle AJ; McGinley JL; Thompson D; Clark R; FitzGerald TL; Mentiplay BF; Lee KJ; Olsen JE; Burnett A; Treyvaud K; Josev E; Alexander B; Kelly CE; Doyle LW; Anderson PJ; Cheong JL
J Physiother; 2016 Oct; 62(4):222-3. PubMed ID: 27634166
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental outcome at 5.5 years in Dutch preterm infants born at 24-26 weeks' gestational age: the EPI-DAF study.
van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman ARC; Mulder-de Tollenaer SM; Steiner K; Swarte RMC; van Westering-Kroon E; Oei G; Leemhuis AG; Andriessen P
Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):272-278. PubMed ID: 38071564
[TBL] [Abstract][Full Text] [Related]
17. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
[TBL] [Abstract][Full Text] [Related]
18. Early Neurodevelopmental Assessments for Predicting Long-Term Outcomes in Infants at High Risk of Cerebral Palsy.
Razak A; Johnston E; Sackett V; Clark M; Charlton M; Zhou L; Pharande P; McDonald CA; Hunt RW; Miller SL; Malhotra A
JAMA Netw Open; 2024 May; 7(5):e2413550. PubMed ID: 38709738
[TBL] [Abstract][Full Text] [Related]
19. Apgar Score and Risk of Cerebral Palsy in Preterm Infants: A Population-Based Cohort Study.
Osredkar D; Verdenik I; Gergeli AT; Gersak K; Lucovnik M
Neuropediatrics; 2021 Aug; 52(4):310-315. PubMed ID: 34162009
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants.
Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE;
JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
